- 25H-NBF
- N-(2-Fluorobenzyl)-2,5-dimethoxyphenethylamine
- 2-(2,5-Dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethan-1-amine
- 2-(2,5-Dimethoxyphenyl)-N-(2-fluorobenzyl)ethan-1-amine
Leth-Petersen, S; Bundgaard, C; Hansen, M; Carnerup, MA; Kehler, J; Kristensen, JL. Correlating the metabolic stability of psychedelic 5-HT2A agonists with anecdotal reports of human oral bioavailability Neurochem. Res., 12 Feb 2014, 39 (10), 2018-2023. 625 kB. https://doi.org/10.1007/s11064-014-1253-y #10c
Pottie, E; Cannaert, A; Stove, CP. In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor Arch. Toxicol., 1 Oct 2020, 94 (10), 3449–3460. 919 kB. https://doi.org/10.1007/s00204-020-02836-w #25H-NBF
Pottie, E; Kupriyanova, OV; Shevyrin, VA; Stove, CP. Synthesis and functional characterization of 2-(2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine (25H-NBF) positional isomers ACS Chem. Neurosci., 5 May 2021, 12 (9), 1667–1673. 3.5 MB. https://doi.org/10.1021/acschemneuro.1c00124 #1 MS,NMR,other
Kupriyanova, OV; Shevyrin, VA; Shafran, YM. Potential of chromatography and mass spectrometry for the differentiation of three series of positional isomers of 2‐(dimethoxyphenyl)‐ N ‐(2‐halogenobenzyl)ethanamines Drug Test. Anal., 1 Jun 2022, 14 (6), 1102–1115. 9.2 MB. https://doi.org/10.1002/dta.3232 #1 GC,LC,MS,NMR,IR